Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Vortioxetine on Cognitive Symptoms in Patients With

NCT04456777 is registered in ClinicalTrials.gov with Alen Greš as lead sponsor.

NCT NCT04456777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04456777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Vortioxetine on Cognitive Symptoms in Patients With
Lead sponsor
Alen Greš
Phase
Phase 1
Overall status
Unknown status
Start date
July 1, 2020
Completion date
July 1, 2022
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive deficit